Singletto Featured as Lead Story in GeekWire

Recently, GeekWire, a rapidly expanding national technology news organization with roots in the Seattle region, highlighted Singletto as a lead story. GeekWire specializes in covering some of the most innovative and unique technology and innovation companies globally.

Synopsis:

Seattle-based startup Singletto has received FDA approval for its Oxafence Active Protection technology, which is incorporated into surgical masks to kill viruses, bacteria, and fungi. The masks utilize methylene blue, a chemical known for its antimicrobial properties and safety in human use. Singletto, founded in 2020 by CEO John Bjornson, Dr. Tom Lendvay, and Dr. Jim Chen, plans to expand the use of this technology to other healthcare items and is partnering with Prestige Ameritech for mask manufacturing.

Read the full article here.